why choose us

First received: August 21, 2023

Clinical Trial: A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Long-term Safety Study of LY3502970 in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone or in Combination With Oral Antihyperglycemic Med

Brief Summary: The purpose of this study is to determine the long-term safety of the study intervention orforglipron as a monotherapy or in combination with oral antihyperglycemic medication.This study includes 3 periods as follows:screening and lead-in period: up to 4 weekstreatment period: 52 weeks, including 20 weeks of dose escalation, andsafety follow-up period: 2 weeks.

Read more